Elizandra Braganhol

Dr. Elizandra Braganhol


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2018 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
JAJuliana Azambuja
Juliana Azambuja
NGN. E. Gelsleichter
N. E. Gelsleichter
LBL. R. Beckenkamp
L. R. Beckenkamp
III. C. Iser
I. C. Iser
MFM. C. Fernandes
M. C. Fernandes
EBElizandra Braganhol
Elizandra Braganhol

29 April 2020 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
JAJuliana Azambuja
Juliana Azambuja
RSR. S. Schuh
R. S. Schuh
LML. R. Michels
L. R. Michels
III. C. Iser
I. C. Iser
LBL. R. Beckenkamp
L. R. Beckenkamp
EBElizandra Braganhol
Elizandra Braganhol

17 October 2016 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
LSLien M Dos Santos
Lien M Dos Santos
TSTatiane M Da Silva
Tatiane M Da Silva
JAJuliana H Azambuja
Juliana H Azambuja
PRPriscila T Ramos
Priscila T Ramos
POPathise S Oliveira
Pathise S Oliveira
EBElizandra Braganhol
Elizandra Braganhol

28 August 2021 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
Dominique Santos RubenichDominique Santos Rubenich
Dominique Santos Rubenich
NONatália Omizzollo
Natália Omizzollo
Mirosław J. SzczepańskiMirosław J. Szczepański
Mirosław J. Szczepański
TRTorsten E. Reichert
Torsten E. Reichert
TWTheresa L. Whiteside
Theresa L. Whiteside
EBElizandra Braganhol
Elizandra Braganhol

1 November 2017 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
JAJuliana H. Azambuja
Juliana H. Azambuja
ESElita F. da Silveira
Elita F. da Silveira
TCTaíse R. de Carvalho
Taíse R. de Carvalho
POPathise S. Oliveira
Pathise S. Oliveira
SPSimone Pacheco
Simone Pacheco
EBElizandra Braganhol
Elizandra Braganhol

24 May 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
DRDominique S. Rubenich
Dominique S. Rubenich
PSPriscila O. de Souza
Priscila O. de Souza
NONatalia Omizzollo
Natalia Omizzollo
MAMariana R. Aubin
Mariana R. Aubin
PBPaulo J. Basso
Paulo J. Basso
EBElizandra Braganhol
Elizandra Braganhol
Introduction: The tumor microenvironment (TME) of glioblastoma (GB) is characterized by an increased infiltration of immunosuppressive cells that attenuate the antitumor immune response. The participation of neutrophils in tumor progression is still controversial and a dual role in the TME has been proposed. In this study, we show that neutrophils are reprogrammed by the tumor to ultimately promote GB progression.Methods: Using in vitro and in vivo assays, we demonstrate the existence of bidirectional GB and neutrophil communication, directly promoting an immunosuppressive TME. Results and discussion: Neutrophils have shown to play an important role in tumor malignancy especially in advanced 3D tumor model and Balb/c nude mice experiments, implying a time- and neutrophil concentration-dependent modulation. Studying the tumor energetic metabolism indicated a mitochondria mismatch shaping the TME secretome. The given data suggests a cytokine milieu in patients with GB that favors the recruitment of neutrophils, sustaining an anti-inflammatory profile which is associated with poor prognosis. Besides, glioma-neutrophil crosstalk has sustained a tumor prolonged activation via NETs formation, indicating the role of NFκB signaling in tumor progression. Moreover, clinical samples have indicated that neutrophil-lymphocyte ratio (NLR), IL-1β, and IL-10 are associated with poor outcomes in patients with GB. Conclusion: These results are relevant for understanding how tumor progression occurs and how immune cells can help in this process.